Dr. Daftary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1996 - 2000
- Seth G.S. Medical CollegeClass of 1992
Certifications & Licensure
- MN State Medical License 2008 - 2025
- ND State Medical License 2016 - 2017
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- Corrigendum to "Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis" [BBA - Mol. Basis of Dis. 1869 (2023) 166784].Joseph Grande, Tiffanny L Jones, Zhifu Sun, Pritha Chanana, Indu Jaiswal
Biochimica Et Biophysica Acta. Molecular Basis of Disease. 2024-03-01 - Reply of the Authors: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders und...Craig A Witz, Kevin J Doody, John K Park, Gaurang S Daftary, Patrick W Heiser
Fertility and Sterility. 2024-02-01 - Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis.Joseph Grande, Tiffanny L Jones, Zhifu Sun, Pritha Chanana, Indu Jaiswal
Biochimica Et Biophysica Acta. Molecular Basis of Disease. 2023-10-01
Press Mentions
- New Clinical Data Published on Menopur (Menotropins for Injection) in a Predicted High Responder PopulationMay 14th, 2020
- Ferring Pharmaceuticals to Present New Fertility Data at ASRM 2019 Scientific Congress & ExpoOctober 14th, 2019
- Ferring Pharmaceuticals Adds Two Products to Its Robust Reproductive Health Portfolio in the U.S.January 14th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: